Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read More
Chris Gibson
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,
Read More